Skip to content

The effects of dietary high-protein yogurt on protein absorption in healthy adult men

The effects of dietary high-protein yogurt on protein absorption in healthy adult men - The effects of dietary high-protein yogurt on protein absorption

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035055
Enrollment
12
Registered
2019-05-31
Start date
2018-10-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult males

Interventions

Single dose administration of 100 g of the high protein yogurt in intervention period Single dose administration of 200 mL of the control unfermented dairy product in control period

Sponsors

Meiji Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) All subjects voluntarily signed the informed consent after detailed description and understanding of this study 2) 20-30 year old men 3) Subjects with BMI within normal range (18.5 kg/m2 =< BMI < 25.0 kg/m2)

Exclusion criteria

Exclusion criteria: 1) Those who were administered ''drug'', such as H2 blocker, PPI, or digestive enzyme preparation, ''medicated products'', such as stomach medicine or digestive drugs, or ''supplement'' containing amino acids or protein, which may have effects on the protein absorption, within one month before the first administration of intervention or control food, or during this study. 2) Patients with diabetes mellitus 3) Patients with diseases or symptoms undergoing treatments 4) Those who may suffer from food allergy 5) Those who may suffer from lactose intolerance 6) Those who have smoking habits 7) Those who donated 200 mL or 400 mL of blood within one month or three months before giving written informed consent, respectively 8) Those who were included other clinical trials within one month before the first administration of intervention or control food, or during this study. 9) Any other medical and/or health reasons unfavorable to participation in this study, as judged by the principal investigator.

Design outcomes

Primary

MeasureTime frame
the blood amino acid areas under the curve (AUC) (total amino acids, essential amino acids, leucine, BCAA)

Secondary

MeasureTime frame
the maximum (Cmax) blood amino acid level (total amino acids, essential amino acids, leucine, BCAA) Blood amino acid level at each blood collection time point (total amino acids, essential amino acids, leucine, BCAA) the time to maximum concentration (Tmax) of amino acids (total amino acids, essential amino acids, leucine, BCAA)

Countries

Japan

Contacts

Public ContactTakaya Kitamura

Meiji Co., Ltd. R&D Total Oversight Department, R&D Division

takaya.kitamura@meiji.com042-632-5807

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026